The world's largest vaccine maker will halve the production of its Covid-19 vaccine because it has no fresh orders, its top-ranking executive has said. India's Serum Institute is sitting on a ...

AstraZeneca, the British pharma giant that developed Covid vaccine Covishield, has admitted in court documents that the vaccine can cause rare side effects, and in some cases, a condition that leads ...

SII's Covishield and Bharat Biotech's Covaxin were India's two main COVID-19 vaccines (File). "We fully understand the ongoing concerns and it is crucial to emphasise our commitment to transparency ...

AstraZeneca has admitted for the first time in court documents that its Covid-19 vaccine, sold globally under the brand names Covishield and Vaxzevria among others, may lead to a rare side-effect.

It is a medical condition characterised by the formation of blood clots (thrombosis) alongside a low blood platelets count (thrombocytopenia). Thrombosis occurs when a clot forms within a blood vessel ...

Serum Institute of India’s status was catapulted from a major pharma company to a name that epitomised hope amid covid gloom, after it announced the development of Covishield vaccine in collaboration ...